VNDA Competitors
Vanda Pharmaceuticals Inc.
$4.25
+$0.03(+0.59%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$255.15M
Volume
430.42K
52W Range
$4.27 - $9.94
Target Price
$11.75
VNDA competitors: NVS, LLY, JNJ, BMY, PFE. Vanda Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VNDA Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVS Novartis AG | $146.88 | $280.27B | $8.89 | 3.25% | 53 |
| LLY Eli Lilly and Company | $1208.74 | $1.14T | $36.19 | 0.55% | 60 |
| JNJ Johnson & Johnson | $253.91 | $599.12B | $11.09 | 2.08% | 56 |
| BMY Bristol-Myers Squibb Company | $59.28 | $121.09B | $6.80 | 3.19% | 63 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VNDA | $4.25 | +0.6% | 430.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vanda Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW